Look at DXCM stock. Now, look at SENS stock. Both are the only serious competitors on the same diabetes market (monitoring and managing). In only one difference, SENS tech is the future, the only sensor in the world lasts 180 days (other sensors last two weeks and very outdated). Now you understand the difference. Now you understand, why you must have it before share price apparently would quadruple very soon now.

Because SENS shares most likely will be 100 times their current price, maybe even 200 or 300 times. As we are talking here of the Trillion$ Diabetes market, not of a neglected disease(even though we must assist people with rare diseases as well). Investmen wise, this is a huge lifetime opportunity, as I see it. $Senseonics Holdings, Inc.(SENS)$ $DexCom(DXCM)$